{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:03:04Z","timestamp":1759334584969,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jfo.2019.08.008","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T17:47:51Z","timestamp":1579542471000},"page":"e107-e108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterozygous type 1 Autosomal Dominant Optic Atrophy (ADOA) with OPA1 c.1936-2A>G genetic variant"],"prefix":"10.1016","volume":"43","author":[{"given":"M.","family":"Mozo-Cuadrado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tabuenca-Del Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belzunce-Manterola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rodr\u00edguez-Ulecia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Morales Gar\u00f3falo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"ClinVar","author":"National Center for Biotechnology Information U.S.","key":"10.1016\/j.jfo.2019.08.008_bib0045"},{"key":"10.1016\/j.jfo.2019.08.008_bib0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.neurol.2010.07.033","article-title":"Hereditary optic atrophies","volume":"166","author":"Scherer","year":"2010","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jfo.2019.08.008_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jfo.2019.08.008_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2019.08.008_bib0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2010.07.029","article-title":"Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies","volume":"118","author":"Yu-Wai-Man","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2019.08.008_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2017.09.018","article-title":"Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: report of 13 Italian families","volume":"382","author":"Pretegiani","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2019.08.008_bib0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2019.08.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ohc.2004.05.005","article-title":"Optic neuropathies caused by toxins and adverse drug reactions","volume":"17","author":"Kerrison","year":"2004","journal-title":"Ophthalmol Clin North Am"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220300140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220300140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:10:31Z","timestamp":1759259431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551220300140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0181551220300140"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2019.08.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous type 1 Autosomal Dominant Optic Atrophy (ADOA) with OPA1 c.1936-2A>G genetic variant","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}